In granulomatous uveitis management, what is the initial treatment described?

In granulomatous uveitis management, what is the initial treatment described?

• A. Steroid Drop Every 2 Hours
• B. Oral Steroids
• C. Antibiotics
• D. Laser Therapy

Answer: (A)

When managing granulomatous uveitis, the priority is rapid suppression of the inflammatory process in the anterior chamber with topical corticosteroids. Using the steroid drop every 2 hours provides a high, consistent concentration of anti-inflammatory medication at the site of inflammation, which is essential for quickly reducing cells and flare and preventing complications like synechiae. This approach minimizes systemic exposure and is the standard first step for noninfectious anterior uveitis, including granulomatous forms. Antibiotics aren’t indicated unless there’s an infectious etiology identified, and laser therapy isn’t a first-line treatment for active inflammation. Oral steroids may be used in more severe or recalcitrant cases or when inflammation isn’t adequately controlled with eye drops, but the initial management described focuses on aggressive topical therapy to rapidly control anterior inflammation.

When managing granulomatous uveitis, the priority is rapid suppression of the inflammatory process in the anterior chamber with topical corticosteroids. Using the steroid drop every 2 hours provides a high, consistent concentration of anti-inflammatory medication at the site of inflammation, which is essential for quickly reducing cells and flare and preventing complications like synechiae. This approach minimizes systemic exposure and is the standard first step for noninfectious anterior uveitis, including granulomatous forms.

Antibiotics aren’t indicated unless there’s an infectious etiology identified, and laser therapy isn’t a first-line treatment for active inflammation. Oral steroids may be used in more severe or recalcitrant cases or when inflammation isn’t adequately controlled with eye drops, but the initial management described focuses on aggressive topical therapy to rapidly control anterior inflammation.